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Abstract: The fields of addiction medicine and addiction research have long sought an efficient 
yet comprehensive instrument to assess patient progress in treatment and recovery. Traditional 
tools are expensive, time consuming, complex, and based on topics that clinicians or research-
ers think are important. Thus, they typically do not provide patient-centered information that is 
meaningful and relevant to the lives of patients with substance use disorders. To improve our 
ability to understand patients’ progress in treatment from their perspectives, the authors and col-
leagues developed a patient-oriented assessment instrument that has considerable advantages over 
existing instruments: brevity, simplicity, ease of administration, orientation to the patient, and 
cost (none). The resulting Treatment Effectiveness Assessment (TEA) elicits patient responses 
that help the patient and the clinician quickly gauge patient progress in treatment and in recovery, 
according to the patients’ sense of what is important within four domains established by prior 
research. Patients provide both numerical responses and representative details on their substance 
use, health, lifestyle, and community. No software is required for data entry or scoring, and no 
formal training is required to administer the TEA. This article describes the development of the 
TEA and the initial phases of its application in clinical practice and in research.
Keywords: substance use disorders, global treatment progress, brief instrument, patient-centered
Introduction
The Affordable Care Act of 2010 in the United States reiterates and strengthens the 
stipulation of addiction as one of the essential care services to be covered at parity 
with other medical conditions. There is great anticipation of a new day dawning in 
addiction treatment, going hand in hand with the development of the electronic health 
records (EHR) system and brief interventions. The Affordable Care Act (ACA) 
recognizes the chronic nature of substance use disorders and emphasizes adoption 
of patient-centered or recovery-oriented, medical home–care models for behavioral 
health care.1,2 Addiction is a chronic disease that requires use of a chronic care model 
and incorporation of patient-reported health outcome measures in order to monitor 
patient progress in a timely manner and to facilitate long-term recovery.
One issue confronting the recovery-oriented approach advanced by the ACA is how 
to measure the treatment outcome of these new interventions quickly and comprehen-
sively, consistent with the evolving trend toward improved efficiency. Use of the EHR 
system has become an essential strategy in improving the efficiency of health care 
delivery, including routine assessments of patient status and progress. Patient-reported 
health outcome measures are needed to be implemented within the EHR system to 
facilitate routine assessments and monitoring of patient progress.3 Researchers in other 
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nations have worked to create efficient outcome assessment 
tools, such as the Treatment Outcome Profile, which is in use 
in the United Kingdom for assessment of patients in treatment 
for substance use disorders.4
Traditional measures such as the Addiction Severity 
Index or the WHO Quality of Life instrument are not cheap 
(although many such assessments are available for free, the 
training and scoring software are not) or brief, and they don’t 
always give clinicians the kind of person-centered informa-
tion that is meaningful and relevant to the lives of patients 
with a substance use disorder. The usual approach to mea-
suring treatment outcomes is to construct lengthy question-
naires based on topics that clinicians or researchers think are 
important and then ask the patients to give answers to those 
questions. These questionnaires are long and complicated or, 
perhaps euphemistically, “comprehensive.” However, they 
may not capture the information that is important in the 
patient’s life or applicable to his/her life situation. Such tra-
ditional questionnaires also cannot be modified to fit each 
particular patient, and they often require the use of complex 
algorithms to determine the level of intervention needed.
The most common questionnaire used by addiction clini-
cians is the Addiction Severity Index (ASI).5 The baseline ASI 
contains 227 questions that query patients in seven functional 
domains: alcohol use, drug use, medical status, psychiatric 
health, employment/self-support, family relations, and illegal 
activity. It takes approximately 45–60 minutes to conduct 
the structured interview.5,6 The shorter version, the ASI-Lite, 
contains 111 items and requires approximately 30–40 min-
utes to administer. ASI training typically takes two full days. 
However, many addiction treatment providers have difficulty 
training new staff (due to a high rate of staff turnover); after 
receiving the ASI’s intensive training, it is always question-
able whether trainees are able to administer the ASI interview 
with clinical integrity.5 Therefore, with increasing pressure 
to offer brief screening, assessment, and treatment interven-
tions as well as emphasis on adoption of a recovery-oriented 
care model, there is a clear need to develop an effective tool 
that is patient-centered and recovery-oriented, and that will 
efficiently and accurately assess the progress of patients in 
treatment and in recovery.
An optimum approach to assessing the progress of 
patients in treatment for substance use disorders would take 
a multidimensional, patient-centered, real-world perspective 
that allows patients to express their perceptions of changes 
in areas that are most pertinent and meaningful to them. 
An assessment tool capable of efficiently eliciting patients’ 
observations on their status and progress in treatment and 
during recovery is needed, especially in response to the 
calls for increased delivery of addiction medicine services 
in primary healthcare settings, and consistent with the Food 
and Drug Administration (FDA)’s current emphasis on 
patient-centered treatment outcomes in clinical research. 
Recognizing the growing need for such a tool, we have 
developed and used, in clinical practice and in research, 
a brief instrument – the Treatment Effectiveness Assessment 
(TEA) – to assess treatment progress and recovery, based 
on the patient’s perspective. The resulting easy-to-complete 
instrument yields results that are relevant to the patient and 
meaningful to both clinicians and patients.
We conducted preliminary evaluations to determine the 
feasibility and clinical utility of the TEA in practice and in 
clinical research. In this article we describe the development 
of the TEA and the early-phase application of the instrument 
in clinical settings. Subsequent manuscripts will describe the 
psychometric properties of the TEA as sufficient data become 
available, perhaps by late 2013.
The need to efficiently  
and comprehensively assess patients  
in treatment and in recovery
Documentation of patient progress is an essential part of clini-
cal care. Over the years, various approaches have been used to 
assess outcomes of substance abuse treatment (eg, diagnosis, 
drug use and related problems, urine testing).7 The traditional 
approaches to assessing treatment progress require consider-
able time and trained staff to administer. Further, they may 
not entirely reflect the changes that are most important to 
patients, because the instruments rely on predetermined 
questions that may not be applicable to patients with diverse 
life experiences and cultural backgrounds. Thus, the resulting 
depiction of progress in treatment and recovery may be of 
uncertain relevance to clinical care. Moreover, the complex-
ity and time-consuming characteristics of these instruments 
inhibit their utility in clinical settings, and as a result, the 
instruments are unevenly incorporated in program evalu-
ation or treatment outcome assessment, if used at all. For 
example, the limited provider time and the pressure to screen 
or assess for multiple medical and psychiatric disorders in 
a busy clinical setting may hinder the adoption of a lengthy 
instrument for screening.8,9
To date, the most widely used instrument for assessing 
treatment outcomes in addiction treatment settings is the 
ASI,5,10 a lengthy questionnaire developed in the early 1980s 
and primarily based on male veterans. Some ASI questions 
may be outdated and uninformative, especially for persons 
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with diverse racial or ethnic backgrounds.5 Clearly, clinicians 
and researchers need a way to find out how patients are doing 
without forcing patients and research participants to endure 
an exhaustive interview or complete a long questionnaire that 
may not be wholly informative to patient progress.
With an increased emphasis on the need for patient-
centered treatment and support from the US federal govern-
ments, there is a need for additional outcome measures that 
are not only patient-centered and recovery-oriented, but 
that can also be adopted effectively by clinicians in clinical 
settings, to provide timely information about the patient 
recovery progress. To this end, we developed a brief, patient-
oriented, easily administered instrument that is practical 
and, most important, relevant to patients in treatment and 
in recovery.
The concept of personal recovery
Recovery is not simply a return to premorbid function-
ing or remission of symptoms; instead, it is about finding 
purposes and meaning in life and engaging in worthwhile 
endeavors, despite one’s health condition.11 Recovery is 
a personal and individual process of growth that unfolds 
along a continuum, and there are multiple pathways to 
recovery.12 The meaning of recovery is related to both the 
illness condition (eg, diagnosis, severity) and personal per-
spectives on hope, confidence, or self-determination (such 
as taking responsibility for life, willingness to ask for help, 
and being connected to others).13,14 Therefore, recovery from 
addiction takes a long-term perspective, involves multiple 
pathways, and involves processes that are unique in timing 
and characteristic for every individual.12 In this regard, a 
person-centered approach to assessment and treatment for 
addiction is needed to understand a patient’s progress, needs, 
and status in recovery.
Consistent with this concept of personal recovery and 
need for establishing a recovery-oriented care system, 
a consensus panel convened by the renowned Betty Ford 
Center for Rehabilitation defined “recovery” as “a vol-
untarily maintained lifestyle characterized by sobriety, 
personal health, and citizenship.”15 Similarly, the Sub-
stance Abuse and Mental Health Services Administration 
defines recovery from a mental or substance use disorder 
as “a process of change through which individuals improve 
their health and wellness, live a self-directed life, and strive 
to reach their full potential.”16 The Substance Abuse and 
Mental Health Services Administration (SAMHSA), in 
2012,16 delineated four major dimensions that support a 
life in recovery:
1. Health: overcoming or managing one’s disease(s) or 
symptoms – for example, abstaining from use of alcohol, 
illicit drugs, and nonprescribed medications if one has 
an addiction problem – and for everyone in recovery, 
making informed, healthy choices that support physical 
and emotional wellbeing;
2. Home: a stable and safe place to live;
3. Purpose: meaningful daily activities – such as a job, study, 
volunteerism, family caretaking, or creative endeavors – 
and the independence, income, and resources to partici-
pate in society; and
4. Community: relationships and social networks that pro-
vide support, friendship, love, and hope.
In a recovery-focused paradigm, a treated patient is neither 
“cured” if abstinent from drugs nor a “treatment failure” if 
there is a relapse to drug use. Rather, the patient is better 
regarded to be in a process of recovery, a continuum that 
may involve periods of abstinence and times of resumed 
drug use.12,17 Routine monitoring of recovery over the long 
term, however, requires assessments that can be administered 
quickly and at low cost, in contrast to those currently in wide 
use, while still capturing the core elements of the recovery 
process.
Development of an efficient, 
patient-centered assessment 
instrument
Consistent with the existing literature on the concept of 
personal recovery,11–14 we have developed a four-item, patient-
centered and recovery-oriented instrument, the TEA, for 
evaluating the status of patient progress and recovery from 
addiction. The TEA directly assesses the patient’s personal 
perspectives on substance use, personal health, lifestyle, 
and responsibility to the community – common elements of 
recovery identified by prior studies, by the consensus panel 
of the Betty Ford Center, and by SAMHSA.12–16 The TEA 
obtains information from patients about specific changes 
that are most salient to them (eg, housing, employment, and 
family relationships). Patients respond to the TEA questions 
providing both numerical responses and brief feedback about 
their situation along the lines of the four categories:
•	 Substance use (drugs, alcohol, tobacco);
•	 Health (eg, physical, emotional health);
•	 Lifestyle (eg, housing or living situation, family, employ-
ment, relationships);
•	 Community (eg, obeying laws and becoming a respon-
sible member of society).
A version of the TEA is presented in Figure S1.
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Treatment effectiveness  
assessment (TEA)
The TEA asks the patient to express the extent of changes 
for the better from his/her involvement in the program to the 
current point (or how things are at baseline, for the first TEA) 
in four areas: substance use, health, lifestyle, and community. 
For each area, the patient is asked to think about how things 
have become better and to circle the results on a 10-point 
scale, where 1 represents “not better at all” and 10 represents 
“very much better.” In each area, the patient is asked to write 
down the one or two changes that have the greatest personal 
importance and is encouraged to add details, explain remarks, 
and make comments.
An essential feature of the TEA is that it allows the 
patients themselves to assign their own “weights” to the 
conditions, perceptions, and behaviors that constitute changes 
in the four domains of recovery. This is consistent with 
another conclusion of the Betty Ford consensus panel, that 
“Individuals who are ‘in recovery’ know what it means to 
them and how important it is in their life. They do not need 
a formal definition.”15 Simply put, they don’t need clinicians 
or researchers to probe too far with a questionnaire; they just 
need to be queried simply, with a few questions to describe 
what changes have occurred that are important or meaning-
ful to them. One patient might define lifestyle improvement 
as landing an entry-level job, another by resuming her law 
practice, and yet another by enrolling in college, which is 
completely in line with the concept of a personal or patient-
centered view on progress in recovery.11,12,14 Researchers and 
clinicians are not in the best position to know what changes 
may have occurred in the lives of patients, and this person-
oriented assessment offers an additional option for clinicians 
and researchers to understand the recovery status from the 
patient’s personal perspective (ie, sensitivity to patient needs 
and changes in status).
Brevity and ease of administration
Brevity and ease of administration are important charac-
teristics promoting adoption by clinicians in a busy treat-
ment setting.8,9 This patient-centered perspective has been 
embraced in the development of the TEA instrument, which 
also benefits from some important lessons learned over the 
past decade regarding instrument development. Although the 
field of psychometrics has long been dominated by the notion 
that “all other things being equal, a long test is a good test,”18 
there is a growing body of literature suggesting that simpler, 
more concise measures of psychological constructs may be 
as good or better than more complex scales. The promise 
of using reduced sets of items is even greater when other 
advantages are taken into account, such as (1) greater statisti-
cal power in regressions, (2) reduced staff and respondent 
burden, and (3) reduced risk of common methods bias.19 
Even with modest error term correlations between items in 
services research, the incremental information gained with 
each additional scale item is often extremely small, and the 
use of longer scales tends to inflate the across-item error terms 
(and annoy respondents).20 Smith et al21 compared results of 
a single-item screen for drug use (“How many times in the 
past year have you used an illegal drug or used a prescription 
medication for nonmedical reasons?”) with the results of the 
ten-item Drug Abuse Screening Test (DAST-10). The single 
item was 100% sensitive and 74% specific for the detection 
of a drug use disorder (as determined by the Composite Diag-
nostic Interview Substance Abuse Module [CIDI-SAM]) – 
almost identical to that of the DAST-10. Citing the time 
constraints in primary care settings, Smith et al advised the 
expanded use of simpler, more straightforward approaches 
to assess patients.21
A study conducted by Farabee et al22 (the Correctional 
Offender Management Profiling for Alternative Sanctions 
[COMPAS]) indicates that certain measures can be shortened 
and/or simplified without any loss of information gained. The 
COMPAS study of needs among prison inmates revealed a 
close relationship between the COMPAS Substance Abuse 
scale (which is based on the Texas Christian University Drug 
Screen [TCUDS], an 18-item, self-administered assessment 
designed for evaluating prison-based treatment programs) 
and the inmates’ responses to a single “yes/no” item added 
to the interview. The investigators simply asked inmates 
whether they felt that they were in need of substance abuse 
treatment. The single-item measure accurately identified 70% 
of the inmates designated as “high need” offenders accord-
ing to the COMPAS and 100% of those designated by the 
COMPAS as “low need.”22
More recently, Wu et al23,24 applied a series of psycho-
metric methods to identify a core set of brief screeners for 
the detection of individuals with an alcohol or drug use 
disorder, in medical settings. The research was conducted 
on large samples of two different national, multisite studies 
and examined all available alcohol and drug use disorders 
in each study (alcohol, amphetamines, cannabis, cocaine, 
opioids, sedatives). Regardless of the sample characteristics 
and substances used, both studies consistently showed that 
use of two dependence items (instead of the seven questions 
designated for assessing a substance dependence disorder) 
can identify patients with an alcohol or drug use disorder.23,24 
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Such psychometric analyses provide evidence that “more 
items is not better,” as some items may be uninformative 
or redundant, adding little information to the utility of an 
instrument.25
Less can be more, and new instruments in the field 
are desirable for their simplicity, if their validity can be 
documented and shown to have advantages over cur-
rent approaches. As that “simpler, more straightforward 
approach,” the TEA offers clinicians a means of efficiently 
and easily assessing individuals in treatment for substance 
use disorders, thereby enhancing the capacity of clini-
cians in mainstream medicine to monitor their progress. 
Furthermore, the TEA is responsive to the increased demand 
for electronic medical records and electronic data collection, 
given its simplicity and brevity, allowing computer-based 
and cell phone-based completion by patients in virtually any 
setting or location. The TEA offers a significant reduction 
in the time and cost required for patient assessment, facili-
tating its implementation. However, its seeming simplicity 
is deceptive; it takes advantage of the computing power of 
the patient’s brain to rapidly screen a host of life activities, 
emphasizing those most relevant to recovery, weighting their 
meaning and value and reducing them to a simple quantifi-
able TEA score.
Generation of quantitative data
The TEA yields a quantitative score that can be easily 
captured in the electronic medical record in a routine-care 
fashion to track the patient’s long-term progress and facilitate 
communications between patients and clinicians. The TEA 
is designed to help the patient and the clinician efficiently 
gauge treatment progress according to the patients’ sense of 
important areas of change and improvement. Patients do their 
own cognitive weightings before assigning a value of 1 (not 
improved or little improved) to 10 (very much improved) to 
each of four recovery-oriented domains: substance use (drugs, 
alcohol, and tobacco), health (physical and emotional), life-
style (eg, housing/living situation, family, employment, rela-
tionships), and community (eg, obeying laws and becoming 
a responsible member of society). The total score is the sum 
of the responses to the four TEA domains, ranging from four 
(no measurable improvement or worse) to 40 (significantly 
improved), based on the changes that have taken place since 
entering the treatment program. The entire assessment takes 
only 2 to 3 minutes. In the course of treatment and during 
recovery, the TEA can be administered periodically in order 
to keep track of how things have or have not changed in some 
key areas of life since beginning treatment and to provide 
some specific examples of events that help the patients to 
assign the significance of such changes, and may help patients 
focus their efforts in recovery. Such a recovery-oriented care 
model has been increasingly recognized as an essential care 
model for persons with a chronic condition, like substance 
use disorder.12,16
While data from our preliminary work with the TEA are 
insufficient for formal psychometric analysis, we were able 
to see a correlation between the TEA scores and the results 
of urine drug testing in that, patients whose urine results 
changed from “positive for illicit drug use” to “negative” 
over the treatment period, showed the greatest TEA change 
score in the drug use domain (N = 9).
In summary, the TEA has considerable advantages over 
existing assessment instruments, which are burdensome to 
researchers, clinicians, and patients. In addition to its brevity 
and ease of administration, a distinguishing feature of the TEA 
is its orientation to the patient. The TEA responses are portrayed 
as a simple, numerical tally that is useful in tracking progress 
over the course of treatment and in recovery. No software is 
required for data entry or scoring. The TEA process may also 
help patients recognize issues needing attention in order to 
achieve a sober, healthy, productive, and balanced life.
Discussion
The development of the TEA was based on decades of clini-
cal practice, reflects the lessons learned from utilization of a 
wide array of assessment instruments in the field, and is well 
advised by the literature, especially some of the more recent 
material on the constructs of “recovery.”15,16,26 We have been 
using and refining the TEA for several years, and we have 
shared the TEA with some local clinicians who have begun 
to use it in their practices. They find it easy to use and easy 
on their patients. Both physicians and patients like it because 
it is easy to understand and easy to do, and doing it pays off 
in ways they hadn’t thought of before. The TEA results give 
both the clinician and the patient specific benchmarks to track 
treatment progress, like recognizing familiar landmarks on a 
journey. For the clinicians, the TEA gives them specific areas 
in their patients’ lives that they know are important for their 
patients and therefore things to pay attention to in treatment. 
For patients, doing the TEA reminds them that their recovery 
has a lot to do with what they do or don’t do in life and that 
changes in their lives are actual, concrete, demonstrable items 
in their recovery.
We have evaluated a small series of patients with TEA, 
ASI, and urine analysis results; while the numbers are too 
small for statistical analysis, inspection of the raw data 
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suggests a positive correlation between their respective 
results. One of us (DL) also collected TEA and urine data 
from a series of patients, and again, there is indication of a 
positive correlation, but since ASI is not part of her practice 
routine, we cannot perform statistical analysis of correlations 
of TEA results with ASI results.
More work is necessary to refine and validate the TEA 
(eg, factor and item response theory analysis, reliability and 
validity research) and to verify its appropriateness for various 
populations (eg, participants in trials of new outpatient phar-
macotherapies, groups of distinct ethnic/racial characteristics, 
non-primary-English speakers, parolees or probationers, 
adolescents, and women, etc). In addition, although we 
examined the relationship between the TEA drug score and 
urine test results in the two pilot studies, similar comparisons 
are also needed for the other domains. For example, future 
research should compare results from selected domains of 
the ASI-Lite (health, financial stability, and legal problems) 
and from the other three TEA domains (health, lifestyle, and 
community) with external criteria (eg, physical exams, the 
Short Form (36) Health Survey [SF-36], employment records, 
and arrests) to assess criterion-related validity.
We also intend to assess the feasibility of implement-
ing the TEA in a broader array of clinical settings, includ-
ing primary care clinics. Given its brevity and promising 
preliminary results, we believe that the TEA will be well 
accepted by patients and clinicians and will be especially 
appealing to primary care physicians who will soon be tasked 
with addressing screening and treatment for substance use 
disorders while maintaining larger caseloads.27 The specific 
events given as key changes underlying the change scores 
also provide data for verification, if desired, and for future 
research. For instance, improvement in drug use can be 
verified by urine drug screen; health status can be checked 
against medical records and data from health care utilization; 
lifestyle changes can be verified by employment records, such 
as pay stubs and tax returns; and community responsibility 
can be checked against arrest records.
We decided to more broadly disseminate the instrument 
by taking advantage of an open access journal so that the TEA 
becomes easily available to practitioners and other readers. 
We think it is timely because this issue confronts everyone 
who has given even a passing thought to what will be needed 
when health reform comes. And since the instrument is so 
simple, requires no formal training, and takes just a few 
minutes to learn and use, we believe many clinicians will 
find it easy to adopt into their practice. Those interested in 
instruments may find ways to validate the TEA – much like 
the psychometric research that has been conducted on the 
Clinical Opioid Withdrawal Score (COWS) – especially in 
settings where their clinical work requires them to perform 
some version of the ASI.
Looking toward a future quantitative examination of the 
TEA, there is an ongoing study that includes the TEA, the 
ASI Lite, and urine toxicology, but it will be 2 years before 
the study is complete and even longer before the results are 
available for our purpose. We decided to share the TEA with 
the treatment community, especially as healthcare reforms are 
imminent; we believe there is little to lose and much to gain 
by making available this efficient, useful instrument now.
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Supplementary figure
Treatment Effectiveness Assessment (TEA)
The TEA asks you to express the extent of changes for the better from your involvement in the program to this point (or how things are 
if it’s your first TEA or baseline) in four areas: substance use, health, lifestyle, and community. For each area, think about how things 
have become better and circle the results on the scale below: the more you have improved, the higher the number – from 1 (not better 
at all) to 10 (very much better). In each area write down the one or two changes most important to you in the Remarks section. Feel free 
to use the back of this page to add details, explain remarks, and make comments.
Substance use: How much better are you with drug and alcohol use? Consider the frequency and amount of use, money spent on 
drugs, amount of drug craving, time spent being loaded, being sick, in trouble and in other drug-using activities, etc.
         None or not much      Better    Much better
1 2 3 4 5 6 7 8 9 10
Remarks:
Health: Has your health improved? In what way and how much? Think about your physical and mental health: Are you eating and 
sleeping properly, exercising, taking care of health problems or dental problems, feeling better about yourself, etc?
         None or not much      Better    Much better
1 2 3 4 5 6 7  8 9  10
Remarks:
Lifestyle: How much better are you in taking care of  personal responsibilities? Think about your living conditions, family situation, 
employment, relationships: Are you paying your bills? Following through with your personal or professional commitments? 
       None or not much       Better    Much better
1 2 3 4  5 6 7  8 9 10
Remarks:
Community:  Are you a better member of the community? Think about things like obeying laws and meeting your responsibilities to 
society: Do your actions have positive or negative impacts on other people? 
     No or not much     Better    Much better
1 2 3 4  5 6 7  8  9  10
Remarks:
Name:      Date:           First TEA?: [    ]
Figure S1 Sample Treatment Effectiveness Assessment (TEA).
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